VI
PRAH

Versor Investments’s PRA Health Sciences, Inc. PRAH Stock Holding History

Versor Investments’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-528,659
Closed -$87.3M – 605
2021
Q2 		$87.3M Buy
528,659
+48,960
+10% +$8.17M 3.07% 8
2021
Q1 		$73.6M Buy
+479,699
New +$65.1M 4.39% 4
2020
Q4 		– Sell
-4,357
Closed -$442K – 297
2020
Q3 		$442K Buy
4,357
+1,100
+34% +$112K 0.04% 169
2020
Q2 		$317K Sell
3,257
-2,642
-45% -$246K 0.03% 134
2020
Q1 		$490K Buy
+5,899
New +$575K 0.03% 116
2019
Q4 		– Sell
-6,600
Closed -$655K – 394
2019
Q3 		$655K Sell
6,600
-4,700
-42% -$467K 0.04% 192
2019
Q2 		$1.12M Buy
11,300
+4,800
+74% +$458K 0.07% 143
2019
Q1 		$717K Buy
6,500
+3,300
+103% +$345K 0.07% 147
2018
Q4 		$294K Sell
3,200
-1,300
-29% -$132K 0.07% 219
2018
Q3 		$496K Sell
4,500
-1,600
-26% -$167K 0.19% 159
2018
Q2 		$569K Sell
6,100
-600
-9% -$51.7K 0.19% 152
2018
Q1 		$556K Buy
+6,700
New +$595K 0.19% 158

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Versor Investments's PRAH Position: Q3 2021 in Review

Versor Investments sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 528,659 shares — an estimated $87.3M sold.

Versor Investments first reported a position in PRAH in Q1 2018 and held it in 12 quarters. The position peaked at $87.3M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Versor Investments reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Versor Investments sold 528,659 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $87.3M.
  • Versor Investments first reported a position in PRA Health Sciences, Inc. in Q1 2018 and held it in 12 quarters.
  • Versor Investments's PRA Health Sciences, Inc. position peaked at $87.3M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Versor Investments's 13F filing for Q3 2021, filed 4 Nov 2021.